アメリカの調製医薬品市場2020-2027:製品種類別(経口薬、局所薬、坐薬・その他)、治療別、流通チャネル別、地域別

◆英語タイトル:USA compounding pharmaceutical Market Size study, by Product Type (Oral medications, Topical medication, suppositories and others), by Therapeutic area (Pain medications, Hormone replacement therapies, Dermatological Distribution Channels and others), by Distribution Channel (Compounding pharmacies and Traditional stores) and Regional Forecasts 2020-2027
◆商品コード:BZW21AP088
◆発行会社(リサーチ会社):Bizwit Research&Consulting
◆発行日:2021年2月15日
◆ページ数:約200
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research&Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research&Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本書では、アメリカの調製医薬品市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、製品種類別(経口薬、局所薬、坐薬、その他)分析、治療別(鎮痛剤、ホルモン補充療法、皮膚科用、その他)分析、流通チャネル別(調剤薬局、従来型店舗)分析、競争状況、調査プロセスなどを整理しました。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・アメリカの調製医薬品市場規模:製品種類別(経口薬、局所薬、坐薬、その他)
・アメリカの調製医薬品市場規模:治療別(鎮痛剤、ホルモン補充療法、皮膚科用、その他)
・アメリカの調製医薬品市場規模:流通チャネル別(調剤薬局、従来型店舗)
・競争状況
・調査プロセス
【レポートの概要】

USA compounding pharmaceutical Market is valued approximately at USD 4.51 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.60% over the forecast period 2020-2027. Compounding is the preparation of a personalized drug mixture to meet a patient’s specific need that cannot be fulfilled by drugs that are commercially available. The compounding pharmaceuticals is gaining a significant demand from various therapeutic areas such pain medication, dermatological applications, hormone replacement therapies and others. Therefore, rising number of skin conditions is stimulating the growth of market over the forecast years. According to the American Academy of Dermatology Association, the primary skin conditions rampant among individuals in the United States include acne, psoriasis and atopic dermatitis.

The compounding pharmaceuticals are precisely recommended by the doctors & dermatologists for the common skin conditions such as acne and psoriasis. Acne is the most common skin condition which affects around 50 million American population every year. Around 85% of the individuals belonging to the age group of 12 to 24 years suffers at least one minor acne. In the present scenario, acne is on the escalating mode in the United States subsequently affecting up to 15% of female population in the country. In addition, Atopic dermatitis is considered as one of the leading skin conditions prevalent among the American population. According to American Academy of Dermatology Association, 1 in 10 individuals in United States would develop atopic dermatitis during their lifetime. The prevalence of atopic dermatitis impacts around 25% of the adolescent and 2-3% of adults in United States every year. Additionally, surging rate of geriatric population is driving the growth of market over the forecast years. However, Denied approval from Food & Drug administration for compounding pharmaceuticals is restraining the growth of market.

Major market player included in this report are:
Fagron
Institutional pharmacy solutions
B.Braun Melsungen AG Company
Athenex pharma solution
Nephron pharmaceuticals corporation
Triangle compounding pharmacy
Fresenius Kabi AG
Rx3 compounding pharmacy
Clinigen group Plc
Pencol compounding pharmacy

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Product Type offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type:
Oral medications
Topical medications
Suppositories
Others

By Therapeutic area:
Pain medications
Hormone replacement therapies
Dermatological applications
Others

By Distribution Channel:
Compounding pharmacies
Traditional stores

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the USA compounding pharmaceutical Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. USA & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Compounding Pharmaceuticals Market, by Product Type, 2018-2027 (USD Billion)
1.2.2. Compounding Pharmaceuticals Market, by Therapeutic area, 2018-2027 (USD Billion)
1.2.3. Compounding Pharmaceuticals Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. USA Compounding Pharmaceuticals Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. USA Compounding Pharmaceuticals Market Dynamics
3.1. Compounding Pharmaceuticals Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. USA Compounding Pharmaceuticals Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. USA Compounding Pharmaceuticals Market, by Product Type
5.1. Market Snapshot
5.2. USA Compounding Pharmaceuticals Market by Product Type, Performance – Potential Analysis
5.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
5.4.1. Oral medications
5.4.2. Topical medications
5.4.3. Suppositories
5.4.4. Others
Chapter 6. USA Compounding Pharmaceuticals Market, by Therapeutic area
6.1. Market Snapshot
6.2. USA Compounding Pharmaceuticals Market by Therapeutic area, Performance – Potential Analysis
6.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Therapeutic area 2017-2027 (USD Billion)
6.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
6.4.1. Pain medications
6.4.2. Hormone replacement therapies
6.4.3. Dermatological applications
6.4.4. Others
Chapter 7. USA Compounding Pharmaceuticals Market, by Distribution channel
7.1. Market Snapshot
7.2. USA Compounding Pharmaceuticals Market by Distribution channel, Performance – Potential Analysis
7.3. USA Compounding Pharmaceuticals Market Estimates & Forecasts by Distribution channel 2017-2027 (USD Billion)
7.4. Compounding Pharmaceuticals Market, Sub Segment Analysis
7.4.1. Compounding pharmacies
7.4.2. Traditional stores
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Fagron
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Type Summary
8.2.1.5. Recent Developments
8.2.2. Institutional pharmacy solutions
8.2.3. B.Braun Melsungen AG Company
8.2.4. Athenex pharma solution
8.2.5. Nephron pharmaceuticals corporation
8.2.6. Triangle compounding pharmacy
8.2.7. Fresenius Kabi AG
8.2.8. Rx3 compounding pharmacy
8.2.9. Clinigen group Plc
8.2.10. Pencol compounding pharmacy
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

List of Tables
TABLE 1. USA Compounding Pharmaceuticals market estimates & forecasts by Product Type 2017-2027 (USD Billion)
TABLE 2. USA Compounding Pharmaceuticals market estimates & forecasts by Therapeutic area 2017-2027 (USD Billion)
TABLE 3. USA Compounding Pharmaceuticals market estimates & forecasts by Application 2017-2027 (USD Billion)
TABLE 4. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 5. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 6. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. USA Compounding Pharmaceuticals market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. USA Compounding Pharmaceuticals market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Years considered for the study
TABLE 21. Exchange rates considered

List of figures
FIG 1. USA Compounding Pharmaceuticals market, research methodology
FIG 2. USA Compounding Pharmaceuticals market, market estimation techniques
FIG 3. USA market size estimates & forecast methods
FIG 4. USA Compounding Pharmaceuticals market, key trends 2019
FIG 5. USA Compounding Pharmaceuticals market, growth prospects 2020-2027
FIG 6. USA Compounding Pharmaceuticals market, porters 5 force model
FIG 7. USA Compounding Pharmaceuticals market, pest analysis
FIG 8. USA Compounding Pharmaceuticals market, value chain analysis
FIG 9. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 10. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 11. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 12. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 13. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 14. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 15. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)
FIG 16. USA Compounding Pharmaceuticals market by segment, 2017 & 2027 (USD Billion)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アメリカの調製医薬品市場2020-2027:製品種類別(経口薬、局所薬、坐薬・その他)、治療別、流通チャネル別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆